glp-1 receptor agonists for weight loss medications Is GLP-1 Safe for Weight

By targeting overlapping yet distinct hormonal pathways, dual incretin therapies aim to amplify weight loss, enhance insulin sensitivity, and improve overall metabolic outcomes beyond what is achievable with GLP-1 receptor agonists alone

2021;372: m4573

Diabetes promotes development of CVD, and at least two classes of diabetes medications have been shown to improve CVD outcomes in patients with diabetes

415,416,417 GLP-1RAs can exert their local effects by activating vagal dendritic terminals that innervate the gut

GLP-1 vs GIP: Understanding Dual Agonist Medications If youve researched weight loss medications, youve probably seen references to GLP-1 agonists like semaglutide and dual GLP-1/GIP agonists like tirzepatide

Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Kber LV, Lawson FC, Ping L, Wei X, Lewis EF